LifeStance Health Group, Inc. (LFST) Guidance & Earnings Results

On 2026-08-06 LifeStance Health Group, Inc. raised guidance: "Revenue raised to $1.685B-$1.725B; Center Margin to $570M-$594M; Adjusted EBITDA to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LFSTLifeStance Health Group, Inc.Follow LFST — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 4.9B
P/E TTM: 99.7
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	Revenue raised to $1.685B-$1.725B; Center Margin to $570M-$594M; Adjusted EBITDA to $215M-$235M · full year
7 May 26	Raised	FY2026 revenue $1.640B-$1.680B (raised); Center Margin $547M-$571M; Adjusted EBITDA $200M-$220M · full year
25 Feb 26	Raised	FY2026 revenue guidance of $1.615-1.655B, Center Margin $526-550M, Adjusted EBITDA $185-205M · full year
6 Nov 25	Raised	Adjusted EBITDA raised to $146M-$152M from prior; Center Margin midpoint raised to $448M-$462M; revenue reiterated $1.41B-$1.43B · full year
7 Aug 25	Raised	FY2025 revenue $1.40B-$1.44B (reiterated); Center Margin $441M-$465M (raised); Adjusted EBITDA $140M-$150M (raised from prior midpoint of $140M). Q3 2025: revenue $345M-$365M; Center Margin $105M-$119M; Adjusted EBITDA $33M-$39M. · full year

LifeStance Health Group, Inc. — questions

What guidance did LifeStance Health Group, Inc. give?: On 2026-08-06: "Revenue raised to $1.685B-$1.725B; Center Margin to $570M-$594M; Adjusted EBITDA to $215M-$235M"
When does LifeStance Health Group, Inc. report earnings?: LifeStance Health Group, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from LifeStance Health Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.